The regulation of GluN2B by the NRG1-ErbB4-Src signaling axis highlighted the importance of NRG1-ErbB4 signaling in symptomatic epilepsy pathology, and the pathway we described here may offer more opportunities for anti-epileptic drug research. The gene discussed is ERBB4; the disease is epilepsy.